Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery
Authors:
- Guanming ShaoGSGuanming Shao
- Yonghui MaYMYonghui Ma
- Chao QuCQChao Qu
- Ruiqian GaoRGRuiqian Gao
- Chengzhan ZhuCZChengzhan Zhu
- Linlin QuLQLinlin Qu
- Kui LiuKLKui Liu
- Na LiNLNa Li
- Peng SunPSPeng Sun
- Jingyu CaoJCJingyu Cao
Open Access
- 1 April 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 11, 679-691
Abstract
Background: Circulating eosinophils are associated with tumor development. An eosinophil-related index, the neutrophil to eosinophil ratio (NER), can be used to predict the prognosis of patients with tumors. However, there is still a lack of efficient prognostic biomarkers for HCC. In this study, we aimed to investigate the predictive value of the NER and develop an optimal machine learning model for the recurrence of HCC patients. Patients and methods: A retrospective collection of 562 patients who underwent hepatectomy with a pathologic diagnosis of HCC was performed. The relationship between NER and progression-free survival (PFS) was investigated. We developed a new machine learning framework with 10 machine learning algorithms and their 101 combinations to select the best model for predicting recurrence after hepatectomy. The performance of the model was assessed by the area under the curve (AUC) of characteristics and calibration curves, and clinical utility was evaluated by decision curve analysis (DCA). Results: Kaplan‒Meier curves showed that the PFS in the low NER group was significantly better than that in the high NER group. Multivariate Cox regression analysis showed that NER was an independent risk factor for recurrence after surgery. The random survival forests (RSF) model was selected as the best model that had good predictive efficacy and outperformed the TNM, BCLC, and CNLC staging systems. Conclusion: The NER has good predictive value for postoperative recurrence in patients with hepatocellular carcinoma. Machine learning model based on NER can be used for accurate predictions.Keywords
This publication has 30 references indexed in Scilit:
- From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatmentCell, 2023
- Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaTargeted Oncology, 2020
- Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanomaCancer Medicine, 2018
- Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with NivolumabJournal of Thoracic Oncology, 2018
- Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation‐based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resectionJournal of Surgical Oncology, 2017
- Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cellsNature Immunology, 2015
- Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular CarcinomaAmerican Journal of Gastroenterology, 2013
- Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganismsNature Reviews Cancer, 2013
- Cancer-Related Symptom Clusters, Eosinophils, and Survival in Hepatobiliary Cancer: An Exploratory StudyJournal of Pain and Symptom Management, 2010
- Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomyJournal of Hepatology, 2003